Ramipril and Klebsiella sepsis - a phase IV clinical study of FDA data

Summary:

Klebsiella sepsis is reported as a side effect among people who take Ramipril (ramipril), especially for people who are female, 60+ old, also take Xigduo Xr, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Klebsiella sepsis when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Klebsiella sepsis?

Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation) is found to be associated with 223 drugs and 452 conditions by eHealthMe. Check the latest studies of Klebsiella sepsis.

On Jul, 11, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 11 people (0.01%) have Klebsiella sepsis.

Among these 11 people:

What is the gender of people who have Klebsiella sepsis when taking Ramipril? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Klebsiella sepsis when taking Ramipril? *

What are other drugs people take besides Ramipril? *

What are other side effects people have besides Klebsiella sepsis? *

Emphysematous Pyelonephritis (presence of gas-producing bacteria in the kidney): 4 people, 36.36%
Pyelonephritis Acute (sudden inflammation of kidney caused by bacteria): 3 people, 27.27%
Enterococcal Sepsis: 2 people, 18.18%
Enterococcal Infection: 1 person, 9.09%
Anaemia (lack of blood): 1 person, 9.09%
Aplasia (defective development or congenital absence of an organ or tissue): 1 person, 9.09%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 9.09%
Bacterial Sepsis: 1 person, 9.09%
Burkitt's Lymphoma Recurrent (recurrent blood cancer): 1 person, 9.09%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 9.09%

What are the existing conditions these people have? *

High Blood Cholesterol: 3 people, 27.27%
Type 2 Diabetes: 2 people, 18.18%
Pain: 2 people, 18.18%
Multiple Myeloma (cancer of the plasma cells): 2 people, 18.18%
Diabetes: 2 people, 18.18%
Depression: 2 people, 18.18%
Stable Angina (a constant chest pain): 1 person, 9.09%
Squamous Cell Carcinoma Of Skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin): 1 person, 9.09%
Scleroderma Renal Crisis (malignant hypertension develops and causes acute renal failure was once a common cause of death): 1 person, 9.09%
Oesophagitis (inflammation of oesophagus): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Klebsiella sepsis?

- Check whether Klebsiella sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Klebsiella sepsis:

Klebsiella sepsis (223 drugs)

Browse all the conditions that are associated with Klebsiella sepsis:

Klebsiella sepsis (452 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.